Heska Co. (NASDAQ:HSKA) Short Interest Up 12.4% in August

Heska Co. (NASDAQ:HSKAGet Rating) saw a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 691,500 shares, an increase of 12.4% from the August 15th total of 615,100 shares. Currently, 6.8% of the company’s shares are short sold. Based on an average daily volume of 94,900 shares, the short-interest ratio is presently 7.3 days.

Analyst Upgrades and Downgrades

Separately, Piper Sandler increased their target price on shares of Heska to $170.00 in a report on Monday, August 22nd. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $184.00.

Heska Trading Down 4.3 %

Shares of HSKA opened at $82.29 on Wednesday. The stock has a market capitalization of $890.30 million, a P/E ratio of -47.84 and a beta of 1.46. The company has a quick ratio of 5.50, a current ratio of 6.92 and a debt-to-equity ratio of 0.24. The firm has a fifty day simple moving average of $89.29 and a two-hundred day simple moving average of $105.59. Heska has a twelve month low of $79.86 and a twelve month high of $269.03.

Institutional Investors Weigh In On Heska

Several institutional investors have recently added to or reduced their stakes in the company. Rhumbline Advisers boosted its position in Heska by 0.4% during the 4th quarter. Rhumbline Advisers now owns 23,386 shares of the medical research company’s stock valued at $4,268,000 after buying an additional 85 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in shares of Heska by 132.0% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 232 shares of the medical research company’s stock worth $32,000 after purchasing an additional 132 shares during the period. Synovus Financial Corp lifted its position in shares of Heska by 2.7% in the 2nd quarter. Synovus Financial Corp now owns 5,199 shares of the medical research company’s stock worth $493,000 after purchasing an additional 138 shares during the period. Teacher Retirement System of Texas lifted its position in shares of Heska by 7.4% in the 1st quarter. Teacher Retirement System of Texas now owns 2,124 shares of the medical research company’s stock worth $294,000 after purchasing an additional 147 shares during the period. Finally, Teachers Retirement System of The State of Kentucky lifted its position in shares of Heska by 5.2% in the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 3,057 shares of the medical research company’s stock worth $423,000 after purchasing an additional 150 shares during the period. Hedge funds and other institutional investors own 97.39% of the company’s stock.

Heska Company Profile

(Get Rating)

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers.

Further Reading

Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.